Specifications Manual for Joint Commission National Quality Measures (v2020A2)
Posted: 10/30/2019
Home » Reason for No Tobacco Cessation Medication at Discharge

Release Notes:
Data Element
Version 2020A2

Name:Reason for No Tobacco Cessation Medication at Discharge
Collected For: TOB-3
Definition:Reasons for not administering an FDA-approved tobacco cessation medication at discharge include:
  • Allergy to all of the FDA-approved tobacco cessation medications.
  • Drug interaction (for all of the FDA-approved medications) with other drugs the patient is currently taking.
  • Patient is pregnant.
  • Other reasons documented by physician, advanced practice nurse(APN), physician assistant (PA), or pharmacist.

Question:Is there documentation of a reason for not prescribing one of the FDA-approved tobacco cessation medications at discharge?
Allowable Values:

Y (Yes)    There is documentation of a reason for not prescribing an FDA-approved cessation medication at discharge

N (No)    There is no documentation of a reasons for not prescribing an FDA-approved cessation medication at discharge or Unable to Determine (UTD) from medical record documentation

Notes for Abstraction:
  • Reasons (other than pregnancy) for not prescribing FDA-approved tobacco cessation medications must be documented by a physician/APN/PA or pharmacist.
  • If there is any documentation in the medical record indicating the patient is pregnant, select “Yes.”
  • An allergy or adverse reaction to one of the FDA-approved cessation medications would not be a reason for not prescribing another of the cessation medications.
  • In determining whether there is a reason documented by physician/APN/PA or pharmacist for not prescribing tobacco cessation medications, the reason must be explicitly documented (e.g., “No tobacco cessation medication as patient is post-operative and nicotine may place them at risk for impaired wound healing”) or clearly implied (e.g., “Patient becomes anxious when they take tobacco cessation medication”). If reasons are not mentioned in the context of cessation medication, do not make inferences (e.g., Do not assume that a tobacco cessation medication is not being prescribed because of the patient's history of recent surgery alone).
  • When conflicting information is documented in the medical record, select Value “No.”
  • If the reason for not prescribing FDA-approved cessation medication is documented at any time during the hospitalization, additional documentation of the reason at the time of discharge is not required.
  • Documentation by the physician, advanced practice nurse (APN), physician assistant (PA), or pharmacist that the patient refused tobacco cessation medication is not considered a valid reason for no tobacco cessation medication at discharge. If refusal is documented as the reason, select Value “No.”
Suggested Data Sources:
  • Anesthesia record
  • Emergency department record
  • History and physical
  • Progress notes
  • Physician orders
  • Discharge summary
  • Medication administration record (MAR)
  • Consultation record
  • Transfer Form
Additional Notes:
Guidelines for Abstraction:
Inclusion Exclusion
  • Allergy or sensitivity
  • Refer to Appendix C, Table 9.1 for a list of FDA-approved tobacco cessation medications
  • Medication allergy using a negative modifier or qualifier (questionable, risk of, suspect, etc.)

Reason for No Tobacco Cessation Medication at Discharge
CPT® only copyright 2019 American Medical Association. All rights reserved.
Specifications Manual for Joint Commission National Quality Measures (v2020A2)
Discharges 01-01-20 (1Q20) through 6-30-20 (2Q20)


CPT® only copyright 2019 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association.

You, your employees and agents are authorized to use CPT® only as contained in The Joint Commission performance measures solely for your own personal use in directly participating in healthcare programs administered by The Joint Commission. You acknowledge that the American Medical Association (“AMA”) holds all copyright, trademark and other rights in CPT®.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT® for resale and/or license, transferring copies of CPT® to any party not bound by this Agreement, creating any modified or derivative work of CPT®, or making any commercial use of CPT®. License to use CPT® for any use not authorized herein must be obtained through the American Medical Association, Intellectual Property Services, AMA Plaza, 330 North Wabash Avenue, Suite 39300, Chicago, Illinois 60611-5885. Applications are available at the American Medical Association Web site, www.ama- assn.org/go/cpt.

U.S. Government Rights This product includes CPT® which is commercial technical data, which was developed exclusively at private expense by the American Medical Association, 330 North Wabash Avenue, Chicago, Illinois 60611. The American Medical Association does not agree to license CPT® to the Federal Government based on the license in FAR 52.227-14 (Data Rights - General) and DFARS 252.227-7015 (Technical Data - Commercial Items) or any other license provision. The American Medical Association reserves all rights to approve any license with any Federal agency.

Disclaimer of Warranties and Liabilities. CPT® is provided “as is” without warranty of any kind, either expressed or implied, including but not limited to the implied warranties of merchantability and fitness for a particular purpose. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT®, and the (AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this product is with The Joint Commission, and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this product.

This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled “accept”.